Skip to main content
. 2022 Sep 21;28:1610659. doi: 10.3389/pore.2022.1610659

FIGURE 3.

FIGURE 3

Phenotypic difference between BTK C481S mutated and wild type CLL samples. The relative expression of CD27, CD69 and CD86 surface markers and the BTK C481S mutation status in the clinically ibrutinib-resistant patients (n = 11) were compared. T-test or Mann-Whitney-test were performed for statistical evaluation. *p < 0.05; **p < 0.01.